Mandate

Vinge advised Sapa on Chinese railways agreement

April 28, 2011

Vinge in Hong Kong has advised Sapa (a wholly owned subsidiary of the Norwegian Orkla ASA) in conjunction with the entry into an agreement with China's largest aluminum company, Chalco, concerning the supply of aluminum profiles to the Chinese railway industry. The joint venture agreement was executed in April this year at a cermony in Beijing attended by 70 specially invited guests. Each party holds 50% of the shares in the joint venture company. In total, the deal relates to an investment of approximately EUR 70 million. The joint venture agreement entails, among other things, that Sapa will be involved in the development of high speed trains for the Chinese market. The agreement has attracted a great deal of interest in both China and Norway.

Vinge's team consisted of Katarina Nilsson, the head of Vinge's China operations.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026